These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9809313)

  • 1. CCK in anxiety and cognitive processes.
    Daugé V; Léna I
    Neurosci Biobehav Rev; 1998 Oct; 22(6):815-25. PubMed ID: 9809313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CCK-B agonist, BC264, increases dopamine in the nucleus accumbens and facilitates motivation and attention after intraperitoneal injection in rats.
    Ladurelle N; Keller G; Blommaert A; Roques BP; Daugé V
    Eur J Neurosci; 1997 Sep; 9(9):1804-14. PubMed ID: 9383203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposite effects of CCK(B) agonists in grooming behaviour in rats: further evidence for two CCK(B) subsites.
    Ladurelle N; Sebret A; Garbay C; Roques BP; Daugé V
    Br J Pharmacol; 1998 Jul; 124(6):1091-8. PubMed ID: 9720778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin and panic disorder: past and future clinical research strategies.
    Bradwejn J; Koszycki D
    Scand J Clin Lab Invest Suppl; 2001; 234():19-27. PubMed ID: 11713976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two faces of cholecystokinin: anxiety and schizophrenia.
    Bourin M; Malinge M; Vasar E; Bradwejn J
    Fundam Clin Pharmacol; 1996; 10(2):116-26. PubMed ID: 8737954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of D2 dopamine receptors in the opposing effects of two CCK-B agonists in a spatial recognition memory task: role of the anterior nucleus accumbens.
    Léna I; Dh tel H; Garbay C; Daugé V
    Psychopharmacology (Berl); 2001 Jan; 153(2):170-9. PubMed ID: 11205416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystokinin and endogenous opioid peptides: interactive influence on pain, cognition, and emotion.
    Hebb AL; Poulin JF; Roach SP; Zacharko RM; Drolet G
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Dec; 29(8):1225-38. PubMed ID: 16242828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations.
    Kõks S; Männistö PT; Bourin M; Shlik J; Vasar V; Vasar E
    J Psychiatry Neurosci; 2000 Jan; 25(1):33-42. PubMed ID: 10721682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid antagonist naloxone potentiates anxiogenic-like action of cholecystokinin agonists in elevated plus-maze.
    Kõks S; Soosaar A; Võikar V; Volke V; Ustav M; Männistö PT; Bourin M; Vasar E
    Neuropeptides; 1998 Jun; 32(3):235-40. PubMed ID: 10189057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cholecystokinin-A and cholecystokinin-B receptors in anxiety.
    Hernandez-Gómez AM; Aguilar-Roblero R; Pérez de la Mora M
    Amino Acids; 2002; 23(1-3):283-90. PubMed ID: 12373548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the significance of cholecystokinin receptors in panic disorder.
    van Megen HJ; den Boer JA; Westenberg HG
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Dec; 18(8):1235-46. PubMed ID: 7863014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive enhancing effects in young and old rats of pBC264, a selective CCK(B) receptor agonist.
    Taghzouti K; Léna I; Dellu F; Roques BP; Daugé V; Simon H
    Psychopharmacology (Berl); 1999 Apr; 143(2):141-9. PubMed ID: 10326776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin and learning and memory processes.
    Hadjiivanova C; Belcheva S; Belcheva I
    Acta Physiol Pharmacol Bulg; 2003; 27(2-3):83-8. PubMed ID: 14570153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecystokinin and panic disorder--three unsettled questions.
    Rehfeld JF
    Regul Pept; 2000 Sep; 93(1-3):79-83. PubMed ID: 11033055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposing effects of two CCK(B) agonists on the retrieval phase of a two-trial memory task after systemic injection in the rat.
    Léna I; Simon H; Roques BP; Daugé V
    Neuropharmacology; 1999 Apr; 38(4):543-53. PubMed ID: 10221758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.
    Singh L; Lewis AS; Field MJ; Hughes J; Woodruff GN
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1130-3. PubMed ID: 1996314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses.
    Abelson JL; Nesse RM
    Biol Psychiatry; 1994 Jul; 36(2):73-83. PubMed ID: 7948449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major biological actions of CCK--a critical evaluation of research findings.
    Fink H; Rex A; Voits M; Voigt JP
    Exp Brain Res; 1998 Nov; 123(1-2):77-83. PubMed ID: 9835394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of dorsolateral periaqueductal gray cholecystokinin-2 receptors in the regulation of a panic-related behavior in rats.
    Bertoglio LJ; Zangrossi H
    Brain Res; 2005 Oct; 1059(1):46-51. PubMed ID: 16168394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of induced effects by selective CCKB agonists cholecystokinin in the nociception and behavior in rodents].
    Dauge V; Derrien M; Durieux C; Noble F; Corringer PJ; Roques BP
    Therapie; 1992 Nov; 47(6):531-9. PubMed ID: 1301645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.